# The Effect of Liraglutide on Pancreatic Hormones and Its Size

> **NCT03520062** · NA · COMPLETED · sponsor: **Nicolai Jacob Wewer Albrechtsen** · enrollment: 14 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Liraglutide (Saxenda) 6Mg/Ml Inj Pen 3Ml

## Key facts

- **NCT ID:** NCT03520062
- **Lead sponsor:** Nicolai Jacob Wewer Albrechtsen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-15
- **Primary completion:** 2019-04-30
- **Final completion:** 2020-01-01
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2020-03-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03520062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03520062, "The Effect of Liraglutide on Pancreatic Hormones and Its Size". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03520062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*